CAPR vs LYB · $1.62B cap vs P/E 21, rev $40.30B
Capricor Therapeutics Inc (CAPR) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
CAPR currently screens at market cap $1.62B. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the CAPR and LYB stock pages for the full models.
Not investment advice.